Your browser doesn't support javascript.
loading
In silico toxicology protocols.
Myatt, Glenn J; Ahlberg, Ernst; Akahori, Yumi; Allen, David; Amberg, Alexander; Anger, Lennart T; Aptula, Aynur; Auerbach, Scott; Beilke, Lisa; Bellion, Phillip; Benigni, Romualdo; Bercu, Joel; Booth, Ewan D; Bower, Dave; Brigo, Alessandro; Burden, Natalie; Cammerer, Zoryana; Cronin, Mark T D; Cross, Kevin P; Custer, Laura; Dettwiler, Magdalena; Dobo, Krista; Ford, Kevin A; Fortin, Marie C; Gad-McDonald, Samantha E; Gellatly, Nichola; Gervais, Véronique; Glover, Kyle P; Glowienke, Susanne; Van Gompel, Jacky; Gutsell, Steve; Hardy, Barry; Harvey, James S; Hillegass, Jedd; Honma, Masamitsu; Hsieh, Jui-Hua; Hsu, Chia-Wen; Hughes, Kathy; Johnson, Candice; Jolly, Robert; Jones, David; Kemper, Ray; Kenyon, Michelle O; Kim, Marlene T; Kruhlak, Naomi L; Kulkarni, Sunil A; Kümmerer, Klaus; Leavitt, Penny; Majer, Bernhard; Masten, Scott.
Afiliação
  • Myatt GJ; Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA. Electronic address: gmyatt@leadscope.com.
  • Ahlberg E; Predictive Compound ADME & Safety, Drug Safety & Metabolism, AstraZeneca IMED Biotech Unit, Mölndal, Sweden.
  • Akahori Y; Chemicals Evaluation and Research Institute, 1-4-25 Kouraku, Bunkyo-ku, Tokyo 112-0004 Japan.
  • Allen D; Integrated Laboratory Systems, Inc., Research Triangle Park, NC, USA.
  • Amberg A; Sanofi, R&D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926 Frankfurt am Main, Germany.
  • Anger LT; Sanofi, R&D Preclinical Safety Frankfurt, Industriepark Hoechst, D-65926 Frankfurt am Main, Germany.
  • Aptula A; Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.
  • Auerbach S; The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, USA.
  • Beilke L; Toxicology Solutions Inc., San Diego, CA, USA.
  • Bellion P; DSM Nutritional Products, Kaiseraugst, Switzerland.
  • Benigni R; Alpha-PreTox, via G.Pascoli 1, 00184 Roma, Italy.
  • Bercu J; Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
  • Booth ED; Syngenta, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.
  • Bower D; Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.
  • Brigo A; Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.
  • Burden N; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.
  • Cammerer Z; Janssen Research & Development, 1400 McKean Road, Spring House, PA 19477, USA.
  • Cronin MTD; School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, L3 3AF, UK.
  • Cross KP; Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.
  • Custer L; Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.
  • Dettwiler M; Elanco Animal Health, Schwarzwaldallee 215, 4058 Basel, Switzerland.
  • Dobo K; Pfizer Global Research & Development, 558 Eastern Point Road, Groton, CT 06340, USA.
  • Ford KA; Global Blood Therapeutics, South San Francisco, CA 94080, USA.
  • Fortin MC; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 170 Frelinghuysen Rd, Piscataway, NJ 08855, USA.
  • Gad-McDonald SE; Gad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC 27609, USA.
  • Gellatly N; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.
  • Gervais V; Biologie Servier, 905 Route de Saran, 45520 Gidy, France.
  • Glover KP; Defense Threat Reduction Agency, Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, USA.
  • Glowienke S; Novartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.
  • Van Gompel J; Janssen Pharmaceutical Companies of Johnson & Johnson, 2340 Beerse, Belgium.
  • Gutsell S; Unilever, Safety and Environmental Assurance Centre, Colworth, Beds, UK.
  • Hardy B; Douglas Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057 Basel / Basel-Stadt, Switzerland.
  • Harvey JS; GlaxoSmithKline Pre-Clinical Development, Park Road, Ware, Hertfordshire, SG12 0DP, UK.
  • Hillegass J; Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.
  • Honma M; National Institute of Health Sciences, Tokyo, Japan.
  • Hsieh JH; Kelly Government Solutions, Research Triangle Park, NC 27709, USA.
  • Hsu CW; FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.
  • Hughes K; Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.
  • Johnson C; Leadscope, Inc., 1393 Dublin Rd, Columbus, OH 43215, USA.
  • Jolly R; Toxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.
  • Jones D; Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London, SW1W 9SZ, UK.
  • Kemper R; Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.
  • Kenyon MO; Pfizer Global Research & Development, 558 Eastern Point Road, Groton, CT 06340, USA.
  • Kim MT; FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.
  • Kruhlak NL; FDA Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.
  • Kulkarni SA; Existing Substances Risk Assessment Bureau, Health Canada, Ottawa, ON, K1A 0K9, Canada.
  • Kümmerer K; Institute for Sustainable and Environmental Chemistry, Leuphana University Lüneburg, Scharnhorststraße 1/C13.311b, 21335 Lüneburg, Germany.
  • Leavitt P; Bristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ 08903, USA.
  • Majer B; Shire, Industriestrasse 20, 1221, Wien, Austria.
  • Masten S; The National Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC 27709, USA.
Regul Toxicol Pharmacol ; 96: 1-17, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29678766

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Simulação por Computador / Testes de Toxicidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxicologia / Simulação por Computador / Testes de Toxicidade Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article